BioSpace News Archive

Contextual Genomics Inc., a leading Canadian cancer genomics company headquartered in Vancouver, Canada, announces that its Scientific Founders, Drs. Samuel Aparicio, David Huntsman and Sohrab Shah, have been recognized by Web of Science (Clarivate Analytics) for their exceptional research performance, as determined by production of multiple highly cited papers that rank in the top 1% by citations for field and year.

In a Twitter sparring match with Jim Hanson, the president of the Security Studies Group, newly elected Rep. Alexandria Ocasio-Cortez (D-N.Y.) wrote: “Actually, we have for-profit ‘death panels’ now: they are companies + boards saying you’re on your own bc they won’t cover a critical procedure or medicine.”

Trimb Healthcare (“Trimb”) has completed the acquisition of BioClin BV (“BioClin”), a leading intimate healthcare company based in Delft, Netherlands.

Technavio analysts forecast the global clinical mass spectrometry market to grow at a CAGR of close to 8% during the forecast period, according to their latest market research report.

The global cardiovascular ultrasound imaging systems market 2019-2023 is expected to post a CAGR of more than 5% during the forecast period, according to the latest market research report by Technavio.

FDA clears XenoTherapeutics’ IND application; Massachusetts General Hospital designated as study center for first-in-human trials

One of the clear trends in the pharmaceutical industry is the rising importance of field medical teams.

Below are experts from the ProfNet network who are available to discuss timely issues in your coverage area.

Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has established an exclusive partnership with Farmacias Magistrales S.A. (“Farmacias”), an established Mexican pharmaceutical manufacturer and distributer with a broad reach to approximately 80,000 retail points and 500 pharmacies and hospitals across Mexico

The impact of Right-to-Try legislation has been in the news a lot recently, but what does the legislation mean for product sponsors? Rho, a full-service contract research organization (CRO), will explore both Right-to-Try legislation and existing Expanded Access Programs in a new free webinar,